Biobehavioral Influences and the Ovarian Tumor Microenvironment
生物行为影响和卵巢肿瘤微环境
基本信息
- 批准号:8656479
- 负责人:
- 金额:$ 4.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-10 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenergic AgentsAreaBehavioralBioinformaticsBiologicalBlood VesselsCancer PatientCardiovascular systemCatecholaminesCellsCellular Tumor SuppressionChronic stressClinicalClinical ResearchDataDiagnosisDiseaseDisease ProgressionEnvironmentEpidemiologic StudiesEpinephrineGelatinase AGenesGenetic TranscriptionGoalsHealthImmune responseInfiltrationInflammationInflammatoryInterleukin-1Interleukin-10Interleukin-6InterventionInvestigationLife StressLigandsLinkLiteratureLocationMacrophage ActivationMalignant Female Reproductive System NeoplasmMalignant neoplasm of ovaryMediatingMediator of activation proteinMental DepressionNorepinephrineOperative Surgical ProceduresOvarian CarcinomaPathway interactionsPatientsPhenotypePhysiologicalPlayPrevalencePrincipal InvestigatorProductionProgression-Free SurvivalsRecruitment ActivityRecurrenceRegulationReportingResearchResourcesRiskRisk FactorsRoleSamplingSignal PathwaySignal TransductionSocial supportStressSurvival RateTNF geneTimeTissuesTranscriptTransforming Growth FactorsTumor AngiogenesisTumor TissueUp-RegulationVascular Endothelial Growth FactorsWorkadrenergicangiogenesisbasebeta-adrenergic receptorbiobehaviorclinically significantcytokinedensitydepressive symptomsgenome-wideinnovationmacrophagemacrophage productmind body interactionmonocyteneoplastic cellnovelovarian neoplasmperipheral bloodprimary outcomepromoterpsychosocialsecondary outcometranscription factortumortumor growthtumor microenvironmenttumor progression
项目摘要
DESCRIPTION (provided by applicant): Ovarian cancer is the second most common gynecologic cancer. Because of low rates of survival for the majority of ovarian cancer patients, identification of factors contributing to tumor progression is of paramount importance. Epidemiologic studies have suggested an association between biobehavioral factors such as life stress, depression, and social support and cancer progression. This study examines a novel pathway that may underlie these links in ovarian cancer, specifically, the relationship of biobehavioral factors with resident macrophages within the tumor microenvironment. It is now acknowledged that the tumor microenvironment is critical in supporting or inhibiting tumor progression. We have previously reported associations of depression and low social support with a poorer cellular immune response in ovarian cancer patients in the tumor microenvironment. We have also demonstrated direct links between biobehavioral factors and cytokines supporting angiogenesis, the formation of new blood vessels that enhance tumor growth and progression. Macrophages are major components of the tumor microenvironment where they are predominantly converted from an anti-tumor phenotype to a pro-tumor phenotype and play a key role in supporting inflammation and tumor progression. However, little is known regarding whether biobehavioral factors influence tumor associated macrophages (TAM) and interactions between TAM and tumor cells in a way that favors tumor growth. Based on compelling preliminary data, we propose that biobehavioral influences on both TAM and tumor cells in the tumor microenvironment have significant effects on production of factors supporting tumor growth and progression. We focus on TAM because of their key role in the tumor microenvironment, and because of indications of macrophage sensitivity to stress factors in the cardiovascular literature and in our preliminary data. Thus, the overarching goal of this proposal is to examine pathways by which biobehavioral factors contribute to a permissive local environment for interactions between resident cells (TAM) and tumor cells that favor tumor growth in ovarian cancer. The proposed project will prospectively examine the relationship of biobehavioral factors (life stress, depression, and social support) and TAM products (inflammatory cytokines and tumor growth factors) in the tumor microenvironment in 206 ovarian cancer patients. Association of biobehavioral factors with upregulation of gene transcripts related to inflammation and proliferation in tumor cells will also be examined. Based on preliminary data we will examine the role of adrenergic signaling as a mediator in these relationships. To determine the clinical significance of these biological alterations, the investigation will assess progression-free and overall survival during the 24 months following diagnosis. Findings will have implications for innovative behavioral and pharmacological intervention strategies for ovarian cancer patients.
描述(申请人提供):卵巢癌是第二常见的妇科癌症。由于大多数卵巢癌患者的生存率较低,因此确定导致肿瘤进展的因素至关重要。流行病学研究表明,生活压力、抑郁和社会支持等生物行为因素与癌症进展之间存在关联。本研究探讨了卵巢癌中可能存在这些联系的新途径,特别是肿瘤微环境中生物行为因素与巨噬细胞的关系。现在已经认识到肿瘤微环境在支持或抑制肿瘤进展中起着至关重要的作用。我们之前报道过卵巢癌患者在肿瘤微环境中较差的细胞免疫反应与抑郁和低社会支持的关联。我们还证明了生物行为因素和支持血管生成的细胞因子之间的直接联系,新血管的形成促进了肿瘤的生长和进展。巨噬细胞是肿瘤微环境的主要组成部分,它们主要从抗肿瘤表型转化为促肿瘤表型,并在支持炎症和肿瘤进展中发挥关键作用。然而,关于生物行为因素是否会影响肿瘤相关巨噬细胞(TAM)以及TAM与肿瘤细胞之间的相互作用,从而促进肿瘤生长,我们知之甚少。基于令人信服的初步数据,我们提出肿瘤微环境中对TAM和肿瘤细胞的生物行为影响对支持肿瘤生长和进展的因子的产生有显著影响。我们关注TAM是因为它们在肿瘤微环境中的关键作用,以及在心血管文献和我们的初步数据中巨噬细胞对应激因子的敏感性。因此,本提案的总体目标是研究生物行为因素如何促成利于卵巢癌肿瘤生长的驻留细胞(TAM)和肿瘤细胞之间相互作用的宽松局部环境的途径。本项目拟前瞻性研究206例卵巢癌患者肿瘤微环境中生物行为因素(生活压力、抑郁、社会支持)与TAM产物(炎症因子、肿瘤生长因子)的关系。生物行为因素与肿瘤细胞炎症和增殖相关基因转录上调的关系也将被研究。基于初步的数据,我们将研究肾上腺素能信号在这些关系中的中介作用。为了确定这些生物学改变的临床意义,研究将评估诊断后24个月内的无进展和总生存期。研究结果将对卵巢癌患者的创新行为和药物干预策略产生影响。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.
- DOI:10.1016/j.bbi.2015.04.010
- 发表时间:2015-10
- 期刊:
- 影响因子:0
- 作者:Schrepf A;Lutgendorf SK;Pyter LM
- 通讯作者:Pyter LM
Out of Mind, Out of Sight: Unexpected Scene Elements Frequently Go Unnoticed Until Primed.
- DOI:10.1007/s12144-013-9184-3
- 发表时间:2013-12-01
- 期刊:
- 影响因子:2.8
- 作者:Slavich, George M.;Zimbardo, Philip G.
- 通讯作者:Zimbardo, Philip G.
Using the stress and adversity inventory as a teaching tool leads to significant learning gains in two courses on stress and health.
使用压力和逆境清单作为教学工具可以在关于压力和健康的两门课程中带来显着的学习收益。
- DOI:10.1002/smi.2523
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Slavich,GeorgeM;Toussaint,Loren
- 通讯作者:Toussaint,Loren
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN K LUTGENDORF其他文献
SUSAN K LUTGENDORF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN K LUTGENDORF', 18)}}的其他基金
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
- 批准号:
10547784 - 财政年份:2020
- 资助金额:
$ 4.43万 - 项目类别:
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
- 批准号:
10064618 - 财政年份:2020
- 资助金额:
$ 4.43万 - 项目类别:
Living Well: A Web-based Intervention to Improve Quality of Life in Rural and Urban Ovarian Cancer Survivors
美好生活:基于网络的干预措施,提高农村和城市卵巢癌幸存者的生活质量
- 批准号:
10329950 - 财政年份:2020
- 资助金额:
$ 4.43万 - 项目类别:
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
行为对卵巢癌进展的影响:化疗耐药的作用
- 批准号:
9029078 - 财政年份:2016
- 资助金额:
$ 4.43万 - 项目类别:
Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors
开发基于网络的团体干预来支持卵巢癌幸存者
- 批准号:
9047253 - 财政年份:2015
- 资助金额:
$ 4.43万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
9569948 - 财政年份:2014
- 资助金额:
$ 4.43万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10176525 - 财政年份:2014
- 资助金额:
$ 4.43万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10425276 - 财政年份:2014
- 资助金额:
$ 4.43万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
9063165 - 财政年份:2014
- 资助金额:
$ 4.43万 - 项目类别:
Mechanisms of Health and Disease at the Behavioral-Biomedical Interface
行为-生物医学界面的健康与疾病机制
- 批准号:
10619011 - 财政年份:2014
- 资助金额:
$ 4.43万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 4.43万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 4.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 4.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 4.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 4.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 4.43万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 4.43万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 4.43万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 4.43万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 4.43万 - 项目类别: